Anupam Rasayan India Ltd announces FY26 results, dividend, auditors, and acquisition plans
Anupam Rasayan India · Chemicals & Petrochemicals
Key highlights
- Approved audited standalone and consolidated financial results for quarter and year ended March 31, 2026
- Recommended final dividend of ₹1.5 per equity share (15% of face value) for FY 2025-26, subject to AGM approval
- Plans acquisition of up to 74.20% equity share capital and control of Bliss GVS Pharma Limited
Why it's rated notable: No price, consideration or completion status is stated for the up-to-74.20% Bliss GVS Pharma acquisition, so the level stays at medium with no amount.
Original filing
Board Meeting Outcome for Outcome Of Board Meeting Held On May 23, 2026.
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Anupam Rasayan India
- Acquisition / mergerNotableAnupam Rasayan completes acquisition of 48.2% controlling stake in Bliss GVS Pharma
- Board / shareholder meeting outcomeNotableAnupam Rasayan India Ltd approves 23rd AGM, dividend record date, Tanfac share acquisition
- Order winNotableAnupam Rasayan signs six-year supply contract with US specialty metal firm
- Fundraise / allotmentMajor developmentAnupam Rasayan India Ltd credit rating updated by Crisil Ratings Limited
- Acquisition / mergerNotableAnupam Rasayan board approves acquisition of up to 74.20% control of Bliss GVS Pharma
Other fundraise / allotment filings this fortnight
- Supreme Engineering allots 14,50,00,000 warrants at ₹2.60 on preferential basis
- Bajaj Finance Limited allots 5.74 crore warrants to Bajaj Finserv on 10 Nov 2026
- Bajaj Finance approves preferential issue of 5.74 crore warrants to Bajaj Finserv
- Chaman Metallics Limited announces H1 FY27 financial results and proposed Rights Issue
- Harmony Capital Services receives BSE approval for preferential issue of shares
- Kuber Udyog: open offer corrigendum, allotments of shares and warrants at ₹23.10
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.